References
- Chang F, Wang L, Syrjänen S., Syrjänen H. Human papillomavirus infections in the respiratory tract. Am J Otolaryngol 1992; 13: 210–25
- Kambič V, Gale N. Epithelial hyperplastic lesions of the larynx. Elsevier, Amsterdam 1995
- Yoder M G, Batsakis J G. Squamous cell carcinoma in solitary laryngeal papilloma. Arch Otolaryngol Head Neck Surg 1980; 88: 745–8
- Majores M, Parkhill E M, Devine K D. Malignant transformation of benign laryngeal papillomas in children after radiation therapy. Surg Clin North Am 1963; 43: 1049–61
- Lindeberg H, Elbrond O. Laryngeal papillomas: clinical aspects in a series of 231 patients. Clin Otolaryngol 1989; 14: 333–42
- Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-erbB related protooncogene, c-erbB-2, is distinct from the c-erbB-1-epidermal growth factor-receptor gene and is amplified in a human salivary gland ade-nocarcinoma. Proc Natl Acad Sci USA 1985; 82: 6497–501
- Field J K, Spandidos D A, Yiagnisis M, Gosney J R, Papadimitriou K, Stell P M. c-erbB-2 expression in squamous cell carcinoma of the head and neck. Anti-cancer Res 1992; 12: 613–20
- Bacus S S, Zelnick C R, Plowman G, Yarden Y. Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Am J Clin Pathol 1994; 102((Suppl 1))13–24
- Underwood M, Bartlett J, Reeves J, Gardiner D S, Scott R, Cooke T. c-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?. Cancer Res 1955; 55: 2422–30
- Chow N H, Huang S M, Chan S H, Mo L R, Hwang M H, Su W C. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. An-ticancer Res 1995; 15: 1055–60
- Kambič V, Lenart I. Notre classification des hyper-plasies de l'épithélium du larynx au point de vue pronostic. JFORL 1971; 20: 1145–50
- Poljak M, Orlowska J, Cerar A. Human papillomavirus infection in esophageal squamous cell papillomas: a study of 29 lesions. Anticancer Res 1995; 15: 965–70
- Werness B A, Arnold J L, Howley P M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76–9
- Scheffner M, Werness B A, Huibregtse J M, Howley P M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129–36
- Li X, Coffino P H. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol 1996; 70: 4509–16
- Fouret P, Dabit D, Sibony M, Alili D, Commo F, Saint-Guily L J, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol 1995; 146: 599–604
- Hall P, Lane D P. p53 in tumour pathology: can we trust immunohistochemistry?. Revisited! J Pathol 1994; 172: 1–4
- Barnes D M, Handby A M, Gillett C E. Abnormal expression of wild-type p53 protein in normal cell of cancer family patient. Lancet 1992; 340: 259–63
- De Potter C R, Quatacker J, Maertens G, van Daele S, Pauwels C, Verhofstede C, et al. The subcellular localisation of the neu protein in human normal and neo-plastic cells. Int J Cancer 1989; 44: 969–74
- Gusterson B A, Machin L G, Gullick W J, et al. c-erbB-2 expression in benign and malignant breast diseases. Br J Cancer 1988; 58: 453–57